Related Experiment Video
Updated: Aug 15, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
Relationship of tumor immunogenicity to concentration of the oncogen
Abstract:
Tumors were induced sc in (BALB/c x DBA/2)F1 female mice by various concentrations of 3-methylcholanthrene (MCA) in paraffin pellets. There was an inverse relationship between MCA concentration and tumor latency (interval between MCA implantation and detection of gross tumor). The tumors were transplanted into syngeneic recipients, and material from this first transplant generation was used to immunize a series of syngeneic mice; any resulting growth was excised. Nonimmunized mice were controls. Immunized and control mice were irradiated and given an sc inoculation of a near-threshold number of tumor cells. Tumor growth from that inoculation was measured weekly in both groups and the antigenicity ratio (mean tumor size in controls/mean tumor size in immunized mice) was calculated. In a series of tumors with similar latencies, the only ones with high antigenicity ratios were those resulting from the high MCA concentration. The results suggested that tumors induced by low levels of oncogen may be good models of spontaneous neoplasia, strengthened the hypothesis that "spontaneous' tumors may actually result from low levels of oncogen, and indicated that neoplastic transformation and the development of immunogenicity are, at least in chemically induced tumors, independent changes that may be produced in the same cell when the concentration of oncogen is sufficient.
Insights
High concentrations of 3-methylcholanthrene (MCA) produced chemically induced tumors with higher immunogenicity. This suggests spontaneous tumors may arise from low-level oncogen exposure, with transformation and immunogenicity being independent changes.
Area of Science:
- Oncology
- Immunology
- Carcinogenesis
Background:
- Chemically induced tumors are used to model spontaneous neoplasia.
- The relationship between oncogen concentration and tumor immunogenicity is not fully understood.
Purpose of the Study:
- To investigate the effect of 3-methylcholanthrene (MCA) concentration on tumor latency and immunogenicity.
- To explore the hypothesis that spontaneous tumors may result from low-level oncogen exposure.
Main Methods:
- Tumors were induced subcutaneously in (BALB/c x DBA/2)F1 female mice using varying concentrations of MCA.
- Tumor-bearing mice were immunized, and tumor cells were inoculated into immunized and control mice.
- Tumor growth and antigenicity ratio were measured to assess immunogenicity.
Main Results:
- An inverse relationship was observed between MCA concentration and tumor latency.
- Tumors induced by high MCA concentrations exhibited higher antigenicity ratios.
- Neoplastic transformation and immunogenicity appear to be independent changes in chemically induced tumors.
Conclusions:
- Tumors induced by low levels of oncogen may serve as effective models for spontaneous neoplasia.
- The findings support the hypothesis that spontaneous tumors could originate from low-level oncogen exposure.
- Sufficient oncogen concentration can lead to independent neoplastic transformation and development of immunogenicity.
Related Concept Videos
The Tumor Microenvironment
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
Tumor Immunotherapy

